SE313301B - - Google Patents
Info
- Publication number
- SE313301B SE313301B SE11503/63A SE1150363DA SE313301B SE 313301 B SE313301 B SE 313301B SE 11503/63 A SE11503/63 A SE 11503/63A SE 1150363D A SE1150363D A SE 1150363DA SE 313301 B SE313301 B SE 313301B
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- ethyl
- group
- compounds
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
- C07C57/50—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/90—Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Abstract
The invention comprises compounds of the formula <FORM:1006588/C2/1> wherein X1 and X each represent a hydrogen atom or together represent a single bond between the two carbon atoms, Y represents a single bond or an oxygen or sulphur atom or the group = NR2 (R2 representing a C1- 6 alkyl group or a hydrogen atom) or a -CH2-CH2- or -CH = CH- group and R1 represents a hydrogen or halogen atom or a C1- 6 alkyl group, and the non-toxic acid addition salts thereof. The preferred compounds are those in which X1, X, and R1 are hydrogen atoms. The compounds are prepared by a variety of methods (a) by condensing 1-phenyl-2-amino-propane with an aldehyde of the formula <FORM:1006588/C2/2> and reducing the azomethine bond in the resultant amino compound of the formula <FORM:1006588/C2/3> and, when X1 and X represent a single bond, optionally hydrogenating the double bono -CH = C<; the condensation may be affected under reducing conditions to give the amind compound directly; (b) by heating of 1-phenyl-2-amino-propane with an acid of the formula <FORM:1006588/C2/4> or the acid halide thereof, and reducing the carbonyl group of the resultant amide of the formula <FORM:1006588/C2/5> to a methylene group; (c) by reductive condensation of phenylacetone and an amine of the formula <FORM:1006588/C2/6> and (d) by the reaction of a compounds <FORM:1006588/C2/7> with a compound <FORM:1006588/C2/8> wherein one of A and B represents a primary amino group and the other represents a halogen atom. Examples describe the preparation of N - [2(10,11 - dihydro - 5H - dibenzo - [a,d]-cycloheptens - 5 - yl) - ethyl]-, N - [2 - (fluoren-9 - yl) - ethyl]-, N - [2 - (5H - dibenzo - [a,d]-cyclohepten - 5 - yl) - ethyl]-, N - [2 - (xanthen-9 - yl) - ethyl]-, N - [2 - (thioxanthen - 9 - yl)-ethyl]-and N - [2 - (9,19 - dihydro - 10 - methyl-acridin - 9 - yl) - ethyl] - 1 - phenyl - 2 - amino-propanes. A number of compounds of the above type wherein R1 is a C1- 6 alkyl, chloro and bromo group are specified. Aldehydes of the formula II may be prepared by condensing a ketone of the formula <FORM:1006588/C2/9> with acetylene to give the alcohol of the formula <FORM:1006588/C2/100> followed by isomerization in the presence of an acid. The aldehydes II may also be obtained by hydrolysis of the corresponding dialkylacetal. Carboxylic acids of the formula VIII are obtained by oxidation of the corresponding aldehyde II or, where X and X1 are hydrogen, by reacting an alcohol of the formula <FORM:1006588/C2/111> with malonic acid to yield a compound <FORM:1006588/C2/122> which is decarboxylated to the mono-acid by heating. The invention includes pharmaceutical compositions comprising at least one of the compounds of formula I, or a non-toxic acid addition salt thereof, which exhibit a dilating activity on the coronary blood vessels and which may be administered orally or parentally in the form of, e.g. tablets, pills, capsules, suspensions, emulsions, syrups, elixirs or unjectable preparations. Example 9 describes a composition in tablet form.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB39753/62A GB1006588A (en) | 1962-10-19 | 1962-10-19 | N-substituted-1-phenyl-2-aminopropanes |
Publications (1)
Publication Number | Publication Date |
---|---|
SE313301B true SE313301B (en) | 1969-08-11 |
Family
ID=10411293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE11503/63A SE313301B (en) | 1962-10-19 | 1963-10-19 |
Country Status (12)
Country | Link |
---|---|
US (1) | US3359263A (en) |
BE (1) | BE638839A (en) |
BR (1) | BR6353836D0 (en) |
CH (1) | CH455754A (en) |
DE (1) | DE1214688B (en) |
DK (2) | DK109925C (en) |
ES (1) | ES292867A1 (en) |
FI (2) | FI42543B (en) |
FR (2) | FR1450391A (en) |
GB (1) | GB1006588A (en) |
NL (2) | NL133997C (en) |
SE (1) | SE313301B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR145F (en) * | 1964-06-01 | |||
US3452009A (en) * | 1965-05-03 | 1969-06-24 | Merck & Co Inc | 2,3-epoxypropylidene derivative of 5h-dibenzo(a,d)-10,11-dihydrocycloheptenes |
US4267192A (en) * | 1980-03-11 | 1981-05-12 | American Home Products Corporation | Method for treating inflammation |
FR2499556B1 (en) * | 1981-02-10 | 1983-03-25 | Cird | |
AU3172397A (en) * | 1996-06-05 | 1998-01-05 | Novartis Ag | Anti-neurodegeneratively effective xanthene derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2676971A (en) * | 1951-04-21 | 1954-04-27 | Searle & Co | Quaternary ammonium derivatives of aminoalkylxanthenes and aminoalkylthiaxanthenes |
US3073847A (en) * | 1959-02-12 | 1963-01-15 | Hoffmann La Roche | 9-(3-amino-1-propynyl) derivatives of 9-xanthenols and 9-thioxanthenols and a process for their preparation |
NL274885A (en) * | 1960-09-16 | |||
BE630063A (en) * | 1962-03-23 | |||
US3258459A (en) * | 1962-08-30 | 1966-06-28 | Squibb & Sons Inc | Method for the preparation of n-monosubstituted-secondary aminoalkyl derivatives of polycyclic compounds |
US3264342A (en) * | 1963-05-24 | 1966-08-02 | Geigy Chem Corp | Derivatives of 5h-dibenzo[a, d] cycloheptene |
US3258488A (en) * | 1963-08-12 | 1966-06-28 | Colgate Palmolive Co | Dibenzo[a, d]cycloheptene derivatives |
-
0
- NL NL299449D patent/NL299449A/xx unknown
- NL NL133997D patent/NL133997C/xx active
- BE BE638839D patent/BE638839A/xx unknown
-
1962
- 1962-10-19 GB GB39753/62A patent/GB1006588A/en not_active Expired
-
1963
- 1963-08-16 US US302707A patent/US3359263A/en not_active Expired - Lifetime
- 1963-10-17 FI FI2027/63A patent/FI42543B/fi active
- 1963-10-18 DE DEN23907A patent/DE1214688B/en active Pending
- 1963-10-18 BR BR153836/63A patent/BR6353836D0/en unknown
- 1963-10-18 CH CH1280863A patent/CH455754A/en unknown
- 1963-10-18 DK DK493363AA patent/DK109925C/en active
- 1963-10-18 FR FR951049A patent/FR1450391A/en not_active Expired
- 1963-10-18 ES ES0292867A patent/ES292867A1/en not_active Expired
- 1963-10-19 SE SE11503/63A patent/SE313301B/xx unknown
-
1964
- 1964-01-17 FR FR960756A patent/FR3974M/fr not_active Expired
-
1966
- 1966-02-21 DK DK90066AA patent/DK111174B/en unknown
-
1969
- 1969-07-28 FI FI2232/69A patent/FI44241B/fi active
Also Published As
Publication number | Publication date |
---|---|
DK109925C (en) | 1968-08-05 |
FI42543B (en) | 1970-06-01 |
NL133997C (en) | |
BR6353836D0 (en) | 1973-07-12 |
BE638839A (en) | |
NL299449A (en) | |
FR1450391A (en) | 1966-06-24 |
DK111174B (en) | 1968-06-24 |
CH455754A (en) | 1968-05-15 |
US3359263A (en) | 1967-12-19 |
ES292867A1 (en) | 1964-04-01 |
DE1214688B (en) | 1966-04-21 |
GB1006588A (en) | 1965-10-06 |
FI44241B (en) | 1971-06-30 |
FR3974M (en) | 1966-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3123646A (en) | Primary acyclic amines | |
DE2205815A1 (en) | N-(oxazolin-2-yl)-piperazine - with antitussive activity | |
Keagle et al. | Tropanone and its Homologs | |
Smith et al. | The Effect of Structure on the Course of the Schmidt Reaction on Unsymmetrical Ketones1 | |
US3859338A (en) | Derivatives of 4-(4'-biphenylyl)-3-or-2-butenoic acid and salts thereof | |
DE1795841C3 (en) | H2'-chloro) -benzyl-2-di-sec.-butylamino-acetyl-pyrrole, its salts and process for their preparation | |
Nordlander et al. | N-(Trifluoroacetyl)-. alpha.-amino acid chlorides as chiral reagents for Friedel-Crafts synthesis | |
GB1006588A (en) | N-substituted-1-phenyl-2-aminopropanes | |
DE2020864B2 (en) | p-Substituted 1-phenoxy-3-alkylaminopropan-2-ols, manufacturing process and pharmaceuticals | |
Fry et al. | The Stevens rearrangement in the benzomorphan synthesis | |
DE2059985A1 (en) | Optically active, basic substituted phenylacetonitrile | |
DE2938571A1 (en) | EPOXYSUCCINAMID ACID COMPOUNDS AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
DE1936206A1 (en) | Diphenylmethoxyaethylamino derivatives and processes for their preparation | |
CH637108A5 (en) | Process for preparing novel 1-aryloxy-2-hydroxy-3-aminopropanes | |
Hurd et al. | Reaction of propiolactone with aniline derivatives | |
Dauben et al. | The Mechanism of the Willgerodt Reaction1 | |
US3507919A (en) | Triphenylpropyl amines | |
Feuer et al. | The Chemistry of Cyclic Hydrazides. 1 VII. The Course of the Michael-Type Addition with Cyclic Hydrazides2 | |
Sax et al. | Retention of configuration in the Wolff rearrangement | |
DE2245467A1 (en) | BENZOIC ACID DERIVATIVES | |
Burckhalter et al. | Esters of α-(2-Dialkylaminoethyl)-benzyl Alcohols | |
GB1220750A (en) | New spiro-azatetramethylene derivatives | |
US3095448A (en) | Cycloalkyl-alkyl hydrazines | |
DE3726633A1 (en) | NEW 1,2-DIAMINO COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
US2824132A (en) | alpha-methyl methionine and salts thereof |